Catalyst-controlled aliphatic C—H oxidations
US-9925528-B2 · Mar 27, 2018 · US
US10611786B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10611786-B2 |
| Application number | US-201816153178-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 5, 2018 |
| Priority date | Oct 9, 2017 |
| Publication date | Apr 7, 2020 |
| Grant date | Apr 7, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Reactions that directly install nitrogen into C—H bonds of complex molecules are significant because of their potential to change the chemical and biological properties of a given compound. Selective intramolecular C—H amination reactions that achieve high levels of reactivity, while maintaining excellent site-selectivity and functional-group tolerance is a challenging problem. Herein is reported a manganese perchlorophthalocyanine catalyst [Mn III (ClPc)] for intermolecular benzylic C—H amination of bioactive molecules and natural products that proceeds with unprecedented levels of reactivity and site-selectivity. In the presence of Brønsted or Lewis acid, the [Mn III (ClPc)]-catalyzed C—H amination demonstrates unique tolerance for tertiary amine, pyridine and benzimidazole functionalities. Mechanistic studies indicate that C—H amination proceeds through an electrophilic metallonitrene intermediate via a stepwise pathway where C—H cleavage is the rate-determining step of the reaction. Collectively these mechanistic features contrast previous base-metal catalyzed C—H aminations. The catalyst can be a compound of Formula I:
Opening claim text (preview).
What is claimed is: 1. A compound of Formula I: wherein X is an anion; each R 1 is independently chloro, bromo, iodo, —C(═O)R 2 , —S(═O) 2 R 3 , —C≡CR 4 , —CQ 3 , or —CQ 2 CQ 3 ; R 2 is H, —CQ 3 , —(C 1 -C 6 )alkyl, OR 5 , N(R 5 ) 2 , or phenyl; R 3 is —CQ 3 , —(C 1 -C 6 )alkyl, N(R 5 ) 2 , or phenyl; R 4 is H, halo, —CQ 3 , —(C 1 -C 6 )alkyl, or phenyl; Q is choro or fluoro; each R 5 is independently H, or —(C 1 -C 6 )alkyl; n is 3 or 4; and the oxidation state of Mn is +3; wherein optionally each phenyl is independently substituted with 1-5 substituents. 2. The compound of claim 1 wherein: each R 1 is independently chloro, bromo, —C(═O)R 2 , —S(═O) 2 R 3 , —CQ 3 , or —CQ 2 CQ. 3. The compound of claim 1 wherein X is halo or SbF 6 . 4. The compound of claim 1 wherein R 1 is chloro. 5. The compound of claim 1 wherein the compound of Formula I is a compound of Formula II: wherein X is Cl or SbF 6 . 6. A composition comprising a compound of claim 1 and a salt. 7. The composition of claim 6 wherein the salt is AgSbF 6 . 8. The composition of claim 6 wherein the compound is 3:
in which the condensed system contains four or more hetero rings · CPC title
Benzo [c] furans; Hydrogenated benzo [c] furans · CPC title
to which a second hetero atom is attached · CPC title
Spiro-condensed ring systems · CPC title
Aza-phenanthrenes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.